Preclinical News and Research

RSS
TrovaGene acquires license to mutations of SF3B1 splicing factor in CLL

TrovaGene acquires license to mutations of SF3B1 splicing factor in CLL

The Scientist selects Aspect Imaging's M2 imaging platform as one of Top 10 Innovations of 2011

The Scientist selects Aspect Imaging's M2 imaging platform as one of Top 10 Innovations of 2011

Speedy drug metabolism more likely to cause multidrug-resistant TB

Speedy drug metabolism more likely to cause multidrug-resistant TB

Emergent commences Phase 2 combination trial of TRUw-016 with bendamustine in relapsed CLL

Emergent commences Phase 2 combination trial of TRUw-016 with bendamustine in relapsed CLL

USPTO issues patent to Novus Scientific's TIGR Matrix Surgical Mesh

USPTO issues patent to Novus Scientific's TIGR Matrix Surgical Mesh

Allergan seeks to reassure surgeons, patients about safety of breast implants

Allergan seeks to reassure surgeons, patients about safety of breast implants

Acceleron Pharma raises $30 million through private financing

Acceleron Pharma raises $30 million through private financing

New way to awaken paternal Ube3a allele linked with Angelman syndrome

New way to awaken paternal Ube3a allele linked with Angelman syndrome

MacroGenics to receive milestone payment from Boehringer Ingelheim

MacroGenics to receive milestone payment from Boehringer Ingelheim

MU Department of Surgery continues to secure research opportunities

MU Department of Surgery continues to secure research opportunities

EETs may also drive growth and spread of cancer

EETs may also drive growth and spread of cancer

New UA cancer research centre to focus on personalised treatment options

New UA cancer research centre to focus on personalised treatment options

Blocking EETs may represent novel strategy for cancer therapy

Blocking EETs may represent novel strategy for cancer therapy

Individualised approach to cancer medicine considering genetic variations

Individualised approach to cancer medicine considering genetic variations

EMA CHMP recommends approval for BioMarin's Novato manufacturing facility expansion

EMA CHMP recommends approval for BioMarin's Novato manufacturing facility expansion

Newgen acquires novel oncology development programs from Kanion

Newgen acquires novel oncology development programs from Kanion

ALS TDI, Biogen Idec and UCB enter agreement to study anti-CD40L antibody for ALS

ALS TDI, Biogen Idec and UCB enter agreement to study anti-CD40L antibody for ALS

New gel could nip Lyme borreliosis infection in the bud

New gel could nip Lyme borreliosis infection in the bud

GSK initiates rhACE2 phase IIa study for Acute Lung Injury

GSK initiates rhACE2 phase IIa study for Acute Lung Injury

Zalicus commences Z944 Phase 1 clinical trial for treatment of acute and inflammatory pain

Zalicus commences Z944 Phase 1 clinical trial for treatment of acute and inflammatory pain

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.